Baxter International Inc (NYSE: BAX) |
|
BAX's Market share relative to its competitors, as of Q4 2024
As of Q4 2024 (Revenue in Millions of $)
Date modified: 2025-04-13T16:46:10+00:00
Select the Relationship:
|
|
Select the Category:
|
|
COMPANY NAME |
REVENUES 12 Months Ending Q4 2024 |
MARKET SHARE 12 Months Q4 2024 |
MARKET SHARE MRQ Q4 2024 |
MARKET SHARE A Quarter Before Q3 2024 |
Baxter International Inc |
10,636.00 |
1.80% |
0.36 % |
1.84 % |
Becton Dickinson And Company |
20,640.00 |
3.50% |
3.51% |
3.70% |
Piedmont Lithium Inc |
99.88 |
0.02% |
0.03% |
0.02% |
Biogen Inc |
9,675.90 |
1.64% |
1.67% |
1.68% |
Pfizer Inc |
63,627.00 |
10.78% |
12.05% |
12.05% |
Merck and Co Inc |
64,168.00 |
10.87% |
10.60% |
11.34% |
Fresenius Medical Care Ag |
21,788.05 |
3.69% |
3.69% |
0.00% |
Avanos Medical Inc |
649.00 |
0.11% |
0.00% |
0.12% |
Helen Of Troy Limited |
2,073.87 |
0.35% |
0.35% |
0.35% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Resmed Inc |
4,775.46 |
0.81% |
0.83% |
0.83% |
Haemonetics Corporation |
1,372.81 |
0.23% |
0.24% |
0.24% |
Outset Medical Inc |
113.56 |
0.02% |
0.02% |
0.02% |
Emergent Biosolutions Inc |
1,043.60 |
0.18% |
0.13% |
0.20% |
Cytosorbents Corporation |
35.13 |
0.01% |
0.00% |
0.01% |
Medtronic Plc |
33,199.00 |
5.62% |
5.62% |
5.72% |
Cardinal Health Inc |
222,160.00 |
37.63% |
37.49% |
35.58% |
Edwards Lifesciences Corporation |
5,439.00 |
0.92% |
0.75% |
0.92% |
3m Company |
26,562.00 |
4.50% |
4.08% |
4.28% |
Axogen inc |
187.34 |
0.03% |
0.03% |
0.03% |
Adapthealth Corp |
3,260.98 |
0.55% |
0.58% |
0.55% |
Icu Medical Inc |
2,382.05 |
0.40% |
0.43% |
0.40% |
Rockwell Medical inc |
101.48 |
0.02% |
0.02% |
0.02% |
Koru Medical Systems Inc |
33.65 |
0.01% |
0.01% |
0.01% |
Avita Medical Inc |
64.25 |
0.01% |
0.01% |
0.01% |
Utah Medical Products Inc |
39.23 |
0.01% |
0.00% |
0.01% |
West Pharmaceutical Services Inc |
2,892.50 |
0.49% |
0.51% |
0.51% |
Abbott Laboratories |
41,950.00 |
7.10% |
7.44% |
7.24% |
Merit Medical Systems Inc |
1,356.33 |
0.23% |
0.24% |
0.23% |
Abiomed Inc |
1,074.10 |
0.18% |
0.18% |
0.19% |
Boston Scientific Corporation |
16,747.00 |
2.84% |
3.09% |
2.86% |
Transmedics Group Inc |
441.54 |
0.07% |
0.08% |
0.07% |
Irhythm Technologies Inc |
591.53 |
0.10% |
0.11% |
0.10% |
Cardiovascular Systems Inc |
239.84 |
0.04% |
0.04% |
0.04% |
Non Invasive Monitoring Systems Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Ir med Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Integra Lifesciences Holdings Corp |
1,610.53 |
0.27% |
0.30% |
0.26% |
Livanova Plc |
1,252.87 |
0.21% |
0.22% |
0.22% |
Penumbra Inc |
1,194.62 |
0.20% |
0.21% |
0.20% |
Inspire Medical Systems inc |
801.82 |
0.14% |
0.16% |
0.14% |
Atricure Inc |
464.52 |
0.08% |
0.08% |
0.08% |
Angiodynamics Inc |
283.00 |
0.05% |
0.05% |
0.05% |
Atrion Corporation |
181.86 |
0.03% |
0.03% |
0.03% |
Silk Road Medical Inc |
114.16 |
0.02% |
0.02% |
0.02% |
Lucid Diagnostics Inc |
4.35 |
0.00% |
0.00% |
0.00% |
Catheter Precision Inc |
0.42 |
0.00% |
0.00% |
0.00% |
Surmodics Inc |
122.77 |
0.02% |
0.02% |
0.02% |
Stryker Corp |
18,449.00 |
3.12% |
3.53% |
3.05% |
Teleflex Incorporated |
3,046.68 |
0.52% |
0.54% |
0.52% |
Artivion Inc |
387.78 |
0.07% |
0.07% |
0.06% |
Meihua International Medical Technologies Co Ltd |
96.20 |
0.02% |
0.02% |
0.00% |
Shockwave Medical Inc |
787.37 |
0.13% |
0.15% |
0.14% |
Lemaitre Vascular Inc |
218.90 |
0.04% |
0.04% |
0.04% |
Inari Medical Inc |
572.18 |
0.10% |
0.10% |
0.10% |
Orchestra Biomed Holdings Inc |
2.64 |
0.00% |
0.00% |
0.00% |
Cvrx inc |
50.96 |
0.01% |
0.01% |
0.01% |
Adagio Medical Holdings inc |
0.00 |
0.00% |
0.00% |
0.00% |
Jin Medical International Ltd |
19.82 |
0.00% |
0.00% |
0.00% |
Yubo International Biotech Limited |
0.37 |
0.00% |
0.00% |
0.00% |
Inspiremd Inc |
6.51 |
0.00% |
0.00% |
0.00% |
Precision Optics Corporation Inc |
20.28 |
0.00% |
0.00% |
0.00% |
Tela Bio Inc |
68.49 |
0.01% |
0.01% |
0.01% |
Stevanato Group S p a |
1,215.60 |
0.21% |
0.21% |
0.00% |
Semler Scientific Inc |
56.29 |
0.01% |
0.01% |
0.01% |
SUBTOTAL |
590,450.05 |
100% |
147,417.89 |
100% |
BAX's Market share relative to its competitors, as of Q4 2024 within the Medical Equipment & Supplies Industry
As of Q4 2024
BAX's Market share relative to its competitors, as of Q4 2024 within the Healthcare Sector
As of Q4 2024
Note: Market share is calculated based on total revenue. To get a more accurate picture of Baxter International Inc's market divisions, geographic dispersion, segments, products, and services, visit Baxter International Inc's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here.
|